학술논문

A truncating mutation in CEP55 is the likely cause of MARCH, a novel syndrome affecting neuronal mitosis
Document Type
Article
Source
Journal of Medical Genetics (JMG); 2017, Vol. 54 Issue: 7 p490-501, 12p
Subject
Language
ISSN
00222593; 14686244
Abstract
BackgroundHydranencephaly is a congenital anomaly leading to replacement of the cerebral hemispheres with a fluid-filled cyst. The goals of this work are to describe a novel autosomal-recessive syndrome that includes hydranencephaly (multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia and hydranencephaly (MARCH)); to identify its genetic cause(s) and to provide functional insight into pathomechanism.MethodsWe used homozygosity mapping and exome sequencing to identify recessive mutations in a single family with three affected fetuses. Immunohistochemistry, RT-PCR and imaging in cell lines, and zebrafish models, were used to explore the function of the gene and the effect of the mutation.ResultsWe identified a homozygous nonsense mutation in CEP55segregating with MARCH. Testing the effect of this allele on patient-derived cells indicated both a reduction of the overall CEP55message and the production of a message that likely gives rise to a truncated protein. Suppression or ablation of cep55lin zebrafish embryos recapitulated key features of MARCH, most notably renal dysplasia, cerebellar hypoplasia and craniofacial abnormalities. These phenotypes could be rescued by full-length but not truncated human CEP55message. Finally, we expressed the truncated form of CEP55 in human cells, where we observed a failure of truncated protein to localise to the midbody, leading to abscission failure and multinucleated daughter cells.ConclusionsCEP55loss of function mutations likely underlie MARCH, a novel multiple congenital anomaly syndrome. This association expands the involvement of centrosomal proteins in human genetic disorders by highlighting a role in midbody function.